Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: FDA

FDA approves Click’s digital therapeutic for episodic migraine

FDA approves Click’s digital therapeutic for episodic migraine
p p Read More

More than 37 million adults in the US are affected by migraine

April 17, 2025 Click Therapeutics, CT-132, digital therapeutics, FDA, News

FDA approves Deciphera’s Romvimza for rare tumour type

FDA approves Deciphera’s Romvimza for rare tumour type
p p Read More

Tenosynovial giant cell tumours can cause pain, stiffness, swelling and movement limitations

February 20, 2025 Deciphera Pharmaceuticals, FDA, News, Romvimza, tenosynovial giant cell tumours, TGCT, US Food and Drug Administration, vimseltinib
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy